NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that multiple ...
Edgewise Therapeutics (EWTX) is drawing attention as it prepares to share new long-term clinical data for its lead drug candidate, sevasemten, at the upcoming World Muscle Society Congress. See our ...
Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics, announced today that two abstracts have been accepted for poster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback